ME00455B - Novi postupak za industrijsku sintezu stroncijum ranelata i njegovih hidrata - Google Patents

Novi postupak za industrijsku sintezu stroncijum ranelata i njegovih hidrata

Info

Publication number
ME00455B
ME00455B MEP-2008-689A MEP68908A ME00455B ME 00455 B ME00455 B ME 00455B ME P68908 A MEP68908 A ME P68908A ME 00455 B ME00455 B ME 00455B
Authority
ME
Montenegro
Prior art keywords
hydrates
novel method
industrial synthesis
strontium ranelate
ranelate
Prior art date
Application number
MEP-2008-689A
Other languages
English (en)
French (fr)
Inventor
Ludot Lucile Vaysse
Pascal Langlois
Jean Piere Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of ME00455B publication Critical patent/ME00455B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

Dati pronalazak odnosi se na postupak za industrijsku sintezu stroncijum ranelata formule (I) i njegovih hidrata.  
MEP-2008-689A 2002-09-24 2003-09-22 Novi postupak za industrijsku sintezu stroncijum ranelata i njegovih hidrata ME00455B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
PCT/FR2003/002777 WO2004029036A1 (fr) 2002-09-24 2003-09-22 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Publications (1)

Publication Number Publication Date
ME00455B true ME00455B (me) 2011-10-10

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-689A ME00455B (me) 2002-09-24 2003-09-22 Novi postupak za industrijsku sintezu stroncijum ranelata i njegovih hidrata

Country Status (38)

Country Link
US (1) US7214805B2 (me)
EP (1) EP1403266B1 (me)
JP (1) JP4136867B2 (me)
KR (1) KR100551501B1 (me)
CN (1) CN1212321C (me)
AP (1) AP1910A (me)
AR (1) AR041355A1 (me)
AU (2) AU2003248281B2 (me)
BR (1) BR0304213A (me)
CA (1) CA2442878C (me)
CR (1) CR7764A (me)
CY (1) CY1115162T1 (me)
DK (1) DK1403266T3 (me)
EA (1) EA007489B1 (me)
EC (1) ECSP055741A (me)
ES (1) ES2478620T3 (me)
FR (1) FR2844795B1 (me)
GE (1) GEP20074215B (me)
HK (1) HK1065791A1 (me)
HR (1) HRP20050359B1 (me)
IL (1) IL167316A (me)
IS (1) IS7807A (me)
MA (1) MA26102A1 (me)
ME (1) ME00455B (me)
MX (1) MXPA03008643A (me)
MY (1) MY134921A (me)
NO (1) NO328638B1 (me)
NZ (1) NZ528402A (me)
OA (1) OA12934A (me)
PL (1) PL214400B1 (me)
PT (1) PT1403266E (me)
RS (2) RS53509B1 (me)
SG (1) SG110071A1 (me)
SI (1) SI1403266T1 (me)
TN (1) TNSN05087A1 (me)
UA (1) UA79156C2 (me)
WO (1) WO2004029036A1 (me)
ZA (1) ZA200307409B (me)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004237438B2 (en) * 2003-05-07 2011-01-20 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
CA2519189C (en) * 2003-05-07 2012-07-17 Osteologix A/S Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
EP1732575B1 (en) * 2004-02-26 2010-12-29 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
JP4954867B2 (ja) * 2004-05-06 2012-06-20 オステオロジックス エイ/エス 有機金属塩類を製造するための高収率で迅速な合成法
DK1768748T4 (da) 2004-06-25 2019-06-11 Mokwalo Spf S A Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
WO2007020527A2 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
US9301945B2 (en) 2011-07-21 2016-04-05 Emory University Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
EP2756841B1 (en) 2013-01-21 2015-05-13 Galenicum Health S.L. Pharmaceutical compositions comprising an acid salt
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Also Published As

Publication number Publication date
US20040063972A1 (en) 2004-04-01
NO20034235D0 (no) 2003-09-23
BR0304213A (pt) 2004-08-31
SI1403266T1 (sl) 2014-06-30
NZ528402A (en) 2004-07-30
DK1403266T3 (da) 2014-07-07
NO328638B1 (no) 2010-04-12
HK1065791A1 (en) 2005-03-04
FR2844795B1 (fr) 2004-10-22
FR2844795A1 (fr) 2004-03-26
PT1403266E (pt) 2014-05-06
EP1403266A1 (fr) 2004-03-31
TNSN05087A1 (fr) 2007-05-14
HRP20050359A2 (en) 2005-06-30
RS53509B1 (en) 2015-02-27
RS20050240A (en) 2007-06-04
PL214400B1 (pl) 2013-07-31
KR20040026625A (ko) 2004-03-31
AP1910A (en) 2008-10-30
JP2004149516A (ja) 2004-05-27
AP2005003256A0 (en) 2005-03-31
OA12934A (en) 2006-10-13
US7214805B2 (en) 2007-05-08
AR041355A1 (es) 2005-05-11
CA2442878A1 (fr) 2004-03-24
CR7764A (es) 2005-10-06
GEP20074215B (en) 2007-10-10
HRP20050359B1 (hr) 2014-09-26
CN1212321C (zh) 2005-07-27
NO20034235L (no) 2004-03-25
SG110071A1 (en) 2005-04-28
UA79156C2 (en) 2007-05-25
AU2003282179A1 (en) 2004-04-19
ECSP055741A (es) 2005-07-06
EP1403266B1 (fr) 2014-04-09
CY1115162T1 (el) 2016-12-14
KR100551501B1 (ko) 2006-02-13
MY134921A (en) 2008-01-31
MXPA03008643A (es) 2005-04-19
CN1496986A (zh) 2004-05-19
EA200300925A1 (ru) 2004-04-29
PL362365A1 (en) 2004-04-05
AU2003248281B2 (en) 2009-08-06
AU2003248281A1 (en) 2004-04-08
WO2004029036A1 (fr) 2004-04-08
CA2442878C (fr) 2009-03-03
ES2478620T3 (es) 2014-07-22
IL167316A (en) 2008-08-07
JP4136867B2 (ja) 2008-08-20
IS7807A (is) 2005-04-19
MA26102A1 (fr) 2004-04-01
ZA200307409B (en) 2004-07-07
EA007489B1 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
ME00455B (me) Novi postupak za industrijsku sintezu stroncijum ranelata i njegovih hidrata
TW200503724A (en) Novel pharmaceuticals
HRP20050361B1 (hr) Novi postupak za industrijsku sintezu tetraestera 5-[bis(karboksimetil)amino]-3-karboksimetil-4-cijano-2-tiofenkarboksilne kiseline i njihova primjena u sintezi bivalentnih soli ranelinske kiseline i njihovih hidrata
HRP20050360B1 (hr) Novi postupak za industrijsku sintezu metil diestera 5-amino-3-karboksimetil-4-cijano-2-tiofenkarboksilne kiseline i njihova primjena u sintezi bivalentnih soli ranelinske kiseline i njihovih hidrata
RS51136B (sr) Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba
EA200702670A1 (ru) Препарат тиенопиридинового ингибитора агрегации тромбоцитов
CY1109854T1 (el) Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
UA97638C2 (ru) Способ синтеза ранелата стронция и его гидратов
GB0127903D0 (en) Improvements relating to organic compounds
EA200500842A1 (ru) Альфа-кристаллическая форма ранелата стронция, способ ее получения и фармацевтические композиции, которые ее содержат
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
TNSN05277A1 (en) Novel bioisosteres of actinonin
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
MEP18708A (en) Process for the production of beraprost and its salts
BRPI0416678A (pt) pirazolpirimidinas
DE602005010369D1 (de) 2-thiaquinolizidines als Glycosidase- und Glycosyltransferase-Inhibitoren
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase
BR0315494A (pt) Compostos azo
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
GB0215392D0 (en) Chemical compounds
MXPA03002493A (es) Proceso eficiente para preparacion de un inhibidor del factor xa.
TW200801011A (en) New compounds II
HU0001287D0 (en) New intermediate and process for its production
CY1106649T1 (el) Νεα 1-μεθοξυ-2-φαινυλ-αιθενια χρησιμα δια την παρασκευην 5-καρβοξαλδεϋδο-2,3-διϋδροβενζοξεπινων